GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mezzion Pharma Co (XKRX:140410) » Definitions » Shiller PE Ratio

Mezzion Pharma Co (XKRX:140410) Shiller PE Ratio : (As of May. 22, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Mezzion Pharma Co Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Mezzion Pharma Co Shiller PE Ratio Historical Data

The historical data trend for Mezzion Pharma Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mezzion Pharma Co Shiller PE Ratio Chart

Mezzion Pharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Mezzion Pharma Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Mezzion Pharma Co's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Mezzion Pharma Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mezzion Pharma Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mezzion Pharma Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Mezzion Pharma Co's Shiller PE Ratio falls into.



Mezzion Pharma Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Mezzion Pharma Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Mezzion Pharma Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2/118.8477*118.8477
=2.000

Current CPI (Mar. 2024) = 118.8477.

Mezzion Pharma Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -50.000 99.353 -59.811
201409 -25.963 99.608 -30.978
201412 -12.622 99.098 -15.137
201503 158.832 99.720 189.298
201506 -24.000 100.050 -28.509
201509 188.514 100.110 223.798
201512 -137.333 100.220 -162.859
201603 -132.667 100.560 -156.794
201606 -214.333 100.790 -252.733
201609 -213.667 101.460 -250.284
201612 -60.333 101.560 -70.603
201703 -221.333 102.850 -255.760
201706 -21.333 102.610 -24.709
201709 -77.333 103.490 -88.809
201712 -346.333 102.990 -399.659
201803 -128.000 104.100 -146.134
201806 -322.667 104.130 -368.273
201809 -468.000 105.650 -526.462
201812 -159.000 104.350 -181.090
201903 -155.000 104.490 -176.298
201906 -168.667 104.880 -191.130
201909 -128.333 105.200 -144.982
201912 -447.667 105.120 -506.128
202003 -119.000 105.540 -134.005
202006 -220.000 104.870 -249.323
202009 -224.333 106.200 -251.050
202012 31.667 105.765 35.584
202103 -83.667 107.357 -92.622
202106 -41.000 107.579 -45.295
202109 -20.000 108.759 -21.855
202112 -243.015 109.676 -263.336
202203 -52.333 111.806 -55.629
202206 -604.000 114.083 -629.227
202209 69.000 114.831 71.413
202212 -677.000 115.200 -698.435
202303 -93.000 116.550 -94.834
202306 -107.000 117.140 -108.560
202309 -33.000 119.111 -32.927
202312 -221.000 118.848 -221.000
202403 2.000 118.848 2.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Mezzion Pharma Co  (XKRX:140410) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Mezzion Pharma Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Mezzion Pharma Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Mezzion Pharma Co (XKRX:140410) Business Description

Traded in Other Exchanges
N/A
Address
C&H, Samseong-dong, 154-8, Gangnam-gu, Dongdaemun-gu, Seoul, KOR, 135-879
Mezzion Pharma Co is a South Korea based drug manufacturer company. It develops and manufactures pharmaceutical products for erectile dysfunction and benign prostatic hyperplasia.

Mezzion Pharma Co (XKRX:140410) Headlines

No Headlines